The Role of Autoantibodies Against G-protein Coupled Receptors in Obesity

Starting soon

Conditions studied: Obesity, Obesity & Overweight, Obesity Type 2 Diabetes Mellitus, Obesity and Obesity-related Medical Conditions

In brief

The purpose of this study is to explore if GPCR-autoantibodies: 1. are pressent in people living with obesity, and are associated with degree of obesity 2. if it is associated with obesity related diseases

Key facts

Study ID

NCT07542327

Run by

Claus Bogh Juhl

People needed

160

Starts

2026-09-01

Expected to finish

2027-09-01

Last updated by the study team

2026-04-24

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Inhabitant in the Region of Southern Denmark
• BMI above 30kg/m2
• age between 18 and 60 years.

You may not qualify if…

• individuals previously treated with GLP-1RA medication for any indication
• Individuals who have previously undergone bariatric surgery
• Individuals with type 1 diabetes

Where it is running

• University Hospital of Southern Denmark, Esbjerg — Esbjerg, Region Syddanmark, Denmark

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.